NVDA
NVIDIA
-- 108.380 TSLA
Tesla
-- 259.160 PLTR
Palantir
-- 84.400 AMZN
Amazon
-- 190.260 AAPL
Apple
-- 222.130 
Rhythm Pharmaceuticals' high P/S ratio is alarming due to it...
Rhythm Pharmaceuticals' high P/S ratio is alarming due to its lower forecast growth compared to the industry. Future revenues may not sustain the positive sentiment, risking shareholders' investments and potential investors may pay a high premium. Investors should note the company's 2 warning signs.
Optimistic Investors Push Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Shares Up 26% But Growth Is Lacking
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment